# Audience Intelligence: Fertility planning tool for men on testosterone

Man on or considering TRT who wants future children is the first audience because the report already names a repeated pain, reachable channels, and a validation test that can be run before software is complete.

## Segments
- **Man on or considering TRT who wants future children**: TRT suppresses sperm production - often reversibly, sometimes not - and most men learn this after starting; fertility-preservation options and adjunct protocols exist but sit outside what prescribing clinics discuss. Trigger: Exogenous testosterone's suppression of spermatogenesis is well-documented, and recovery timelines after discontinuation vary widely. Budget signal: Affiliate/referral revenue from sperm-banking and fertility clinics plus a premium planning subscription.
- **Budget owner who feels the operational cost of the broken workflow.**: Clinical-advice adjacency demands careful medical review and disclaimers. Trigger: AI-assisted product work and managed infrastructure reduce the first-version cost. Budget signal: $49-$499/month
- **Hands-on operator willing to pilot a narrow tool before a full rollout.**: Audience overlap with #59 suggests these may merge into one product. Trigger: Affiliate/referral revenue from sperm-banking and fertility clinics plus a premium planning subscription. Budget signal: $99-$1,000/year add-on
- **Man on or considering TRT who wants future children who still run the workflow in spreadsheets, generic docs, email, or chat threads.**: TRT suppresses sperm production - often reversibly, sometimes not - and most men learn this after starting; fertility-preservation options and adjunct protocols exist but sit outside what prescribing clinics discuss. Trigger: The wedge is specific enough to test without claiming the whole market. Budget signal: Custom

## Channels
- **Reddit / forums**: Look for complaints, workarounds, and repeated questions. First move: Post a problem teardown for Men's reproductive health and ask how people solve it today.
- **Launch communities**: Launch traction shows whether the promise is legible. First move: Ship a narrow demo and watch which promise gets clicks.
- **Review and alternative pages**: Pricing and alternatives expose buyer objections. First move: Write an alternatives page that owns one narrow use case.
- **Community pain posts**: Use communities and forums where Man on or considering TRT who wants future children already describe the painful workflow. First move: Problem teardown, interview ask, and short demo clip
- **Direct outreach**: Direct conversations are the fastest way to verify budget ownership and switching cost. First move: Concierge pilot offer with a manually prepared sample

## Intent Keywords
`fertility workflow`, `planning validation`, `fertility ai`, `planning automation`, `digital-health`, `fertility`, `Men's reproductive health`

## Messaging Angles
- Fertility planning tool for men on testosterone should be tested as a narrow first-win workflow for one buyer: Man on or considering TRT who wants future children.
- Replace a narrow workflow that reaches value without configuration-heavy onboarding. with a focused first-win workflow.
- Promise proof around problem resonance: 5+ calls or 10+ detailed replies..
- De-risk adoption with concierge review or paid template.

## Objections
- Clinical-advice adjacency demands careful medical review and disclaimers.
- Audience overlap with #59 suggests these may merge into one product.
- Needs real buyer access, not only desk research.
- Needs proof of budget or repeated urgency.
- Needs a crisp wedge before broad product work starts.
- A broad AI assistant can flatten differentiation unless the wedge is painfully specific.